Dimensional Fund Advisors LP Sells 76,859 Shares of DaVita Inc. (NYSE:DVA)

Dimensional Fund Advisors LP cut its position in shares of DaVita Inc. (NYSE:DVA - Free Report) by 7.8% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 902,418 shares of the company's stock after selling 76,859 shares during the quarter. Dimensional Fund Advisors LP owned about 1.10% of DaVita worth $134,959,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. Epoch Investment Partners Inc. purchased a new stake in shares of DaVita in the fourth quarter worth $55,100,000. Freedom Investment Management Inc. boosted its stake in DaVita by 3.6% in the 4th quarter. Freedom Investment Management Inc. now owns 1,790 shares of the company's stock worth $268,000 after purchasing an additional 62 shares in the last quarter. GeoWealth Management LLC grew its position in DaVita by 30.6% during the 4th quarter. GeoWealth Management LLC now owns 525 shares of the company's stock valued at $79,000 after purchasing an additional 123 shares during the last quarter. Arrow Capital Pty Ltd bought a new stake in DaVita during the 4th quarter valued at about $1,496,000. Finally, Farringdon Capital Ltd. bought a new position in shares of DaVita in the fourth quarter worth approximately $231,000. Institutional investors own 90.12% of the company's stock.

Wall Street Analyst Weigh In

Several analysts have commented on the company. Sanford C. Bernstein set a $184.00 target price on DaVita in a research note on Friday, February 21st. Cowen reiterated a "hold" rating on shares of DaVita in a report on Tuesday, February 18th. Barclays upped their target price on shares of DaVita from $164.00 to $169.00 and gave the company an "equal weight" rating in a research note on Tuesday, February 18th. Finally, StockNews.com raised shares of DaVita from a "hold" rating to a "buy" rating in a report on Friday. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $166.33.

DaVita Trading Up 0.0 %

Shares of DVA opened at $139.57 on Friday. The stock has a market capitalization of $11.17 billion, a PE ratio of 13.00, a P/E/G ratio of 1.07 and a beta of 1.04. The company's fifty day moving average is $146.50 and its 200 day moving average is $155.30. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.21 and a current ratio of 1.26. DaVita Inc. has a fifty-two week low of $130.96 and a fifty-two week high of $179.60.

DaVita (NYSE:DVA - Get Free Report) last posted its quarterly earnings data on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, topping analysts' consensus estimates of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. Sell-side analysts expect that DaVita Inc. will post 10.76 earnings per share for the current fiscal year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DaVita Inc. (NYSE:DVA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.